On August 25, 2016, Weitz & Luxenberg P.C. of counsel attorney Ellen Relkin is speaking at the LexisNexis complimentary CLE-eligible webinar “ADR for Complex Claims:Choosing and Using the Most Effective Resolution Instruments.” This 90-minute, audio-only webinar begins at 2:00 p.m. ET.
This program is geared toward law firm professionals, state and local government representatives, and corporate counsel. Designed to illuminate and share best practices regarding alternative dispute resolution, this webinar may appeal to those specializing in just about any area of law who want to learn more about complex, multifaceted claims.
In preparation for the event, participants may log in and dial in from their location. Audience members will be encouraged to ask questions using an online chat feature.
The Honorable Marina Corodemus (Ret.), an award-winning arbitrator and mediator, moderates this webinar, which features a panel of accomplished, highly esteemed experts. Relkin is speaking on medical devices during the program’s focus on complex drug and medical device claims.
“It is an honor to be invited to join such a prestigious panel of veteran attorneys,” said Relkin.
Relkin, who has represented thousands of individuals over the years, specializes in medical device and pharmaceutical product liability. Regularly recognized as a “Super Lawyer” in New York and New Jersey, Relkin has, in recent years, committed herself to seeking justice for those injured by defective metal-on-metal and modular hip implants, as well as other faulty medical devices.
Courts consistently call upon her to serve in leadership capacities. She was appointed Co-Lead Counsel for the In Re: DePuy ASR Multi-District Litigation, Lead and Liaison Counsel for the New Jersey In Re: Stryker Rejuvenate & ABG II Modular Hip Implant Litigation.
Relkin also serves on the Plaintiffs’ Steering Committee in the In Re: Xarelto Product Liability Litigation and had served on the court-appointed Plaintiffs’ Steering Committee of the In Re: Biomet Hip Implant Litigation.